The FDA has authorized mRNA Covid-19 booster shots designed to protect against the original strain of the novel coronavirus, as well as the two omicron subvariants that are currently driving U.S. caseloads. An advisory committee to the CDC is scheduled to discuss these vaccines and vote on their recommended use on Thursday.
Covid-19 vaccines from Pfizer and Moderna now have FDA emergency use authorization for children as young as 6 months old. If the Centers for Disease Control and Prevention signs off on these shots this weekend, these pediatric vaccines could become available for distribution early next week.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Verily has pulled off a recruitment coup, hiring former FDA Commissioner Robert Califf as a company advisor. It comes at a crucial time as top talent leaves and criticism of CEO Andrew Conrad persists.
Dr. Robert Califf, who stepped down last month, offers five tips about keeping Americans safe — and making sure drugs actually work — after about a year overseeing the federal agency.
Muhammad Ali announced many years ago that he suffered from Parkinson’s disease, but Dr. Bennet Omalu thinks differently, hypothesizing the boxer may have suffered from CTE.
Plus, biopharma CEOs grow bearish about their ability to raise new capital, Hollywood Presbyterian ransomware attack may be just the beginning and incoming Dana-Farber CEO is excited for the future.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The verdict is still out about Dr. Robert Califf. Does he have the right intentions in order to ethically lead the FDA?
Also, Sean Parker donates $10 million for diabetes, a look at the FDA's lab-testing regulation plans, the potential for a notable New England healthcare merger, and a CES preview (really? A CES preview in November).
Rob Califf, the freshly nominated candidate for FDA Commissioner, has deep expertise in large-scale clinical trial design and regulatory policy. What are his strengths?
Dr. Margaret Hamburg will be stepping down from her position as commissioner of the U.S. Food and Drug Administration after being appointed by President Obama nearly six years ago. Hamburg has overseen initiatives including personalized medicine, disease control, medical device and drug approval, food safety and tobacco control. Reuters reported that the news comes from […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.